T
Tamaki Kato
Researcher at Kyushu Institute of Technology
Publications - 71
Citations - 1196
Tamaki Kato is an academic researcher from Kyushu Institute of Technology. The author has contributed to research in topics: Tetrapeptide & Histone deacetylase. The author has an hindex of 17, co-authored 68 publications receiving 1135 citations.
Papers
More filters
Journal Article
Cyclic Hydroxamic-acid-containing Peptide 31, a Potent Synthetic Histone Deacetylase Inhibitor with Antitumor Activity
Yasuhiko Komatsu,Kin-ya Tomizaki,Makiko Tsukamoto,Tamaki Kato,Norikazu Nishino,Shigeo Sato,Takao Yamori,Takashi Tsuruo,Ryohei Furumai,Minoru Yoshida,Sueharu Horinouchi,Hideya Hayashi +11 more
TL;DR: CHAP31 was selected as one of the strongest CHAPs, and its biological activity was characterized further, and suggested to be promising as a novel therapeutic agent for cancer treatment.
Journal ArticleDOI
Quasi-solid dye sensitised solar cells filled with ionic liquid--increase in efficiencies by specific interaction between conductive polymers and gelators
Y. Shibata,Tamaki Kato,Takashi Kado,R. Shiratuchi,Wataru Takashima,Keiichi Kaneto,Shuzi Hayase +6 more
TL;DR: Photo-energy conversions for quasi-solid dye sensitised solar cells increased when gel electrolytes were combined with conductive polymers as counter electrodes and the conversion surpassed that for DSSCs equipped with conventional Pt counter electrodes.
Journal ArticleDOI
Quasi-solid dye sensitized solar cells solidified with chemically cross-linked gelators: Control of TiO2/gel electrolytes and counter Pt/gel electrolytes interfaces
Shohei Sakaguchi,H Ueki,Tamaki Kato,Takashi Kado,R. Shiratuchi,Wataru Takashima,Keiichi Kaneto,Shuji Hayase +7 more
TL;DR: In this article, a small amount of water was added in order to decrease initial viscosities for ionic liquid type gel precursors to impregnate into nano-pores in TiO2 layers.
Journal ArticleDOI
Cyclic tetrapeptides bearing a sulfhydryl group potently inhibit histone deacetylases.
Norikazu Nishino,Binoy Jose,Shinji Okamura,Shutoku Ebisusaki,Tamaki Kato,Yuko Sumida,Minoru Yoshida +6 more
TL;DR: New inhibitors of histone deacetylase (HDAC) containing a sulfhydryl group were designed on the basis of the corresponding hydroxamic acid (CHAP31) and FK228 and exhibited potent HDAC inhibitory activity in vivo with potential as anticancer prodrugs.
Journal ArticleDOI
Novel histone deacetylase inhibitors: cyclic tetrapeptide with trifluoromethyl and pentafluoroethyl ketones.
TL;DR: Cyclic tetrapeptides containing trifluoromethyl and pentafluoroethyl ketone as zinc binding functional group were synthesized as potent HDAC inhibitors and showed to be promising anticancer agents.